![Paul Berns](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paul Berns
Gründer bei
NEUMORA THERAPEUTICS, INC.
Vermögen: 11 Mio $ am 31.08.2026
Profil
Paul L.
Berns founded HIBio, Inc. in 2021, where he worked as Chairman from 2021 to 2024, Neumora Therapeutics, Inc. in 2019, where he is working as Executive Chairman from 2026, and Ollin Biosciences, Inc. in 2023, where he is working as Executive Chairman from 2023.
Mr. Berns also founded Salma Health, Inc., where he is working as Director and Tenvie Therapeutics, Inc., where he is working as Executive Chairman.
Mr. Berns also currently works at Happy Ai Software, Inc., as Chairman, Human Immunology Biosciences, Inc., as Chairman from 2021, Epirium Bio, Inc., as Director, and various other companies.
Mr. Berns also formerly worked at Bone Care International, Inc., as President, Chief Executive Officer & Director from 2002 to 2005, Allos Therapeutics, Inc., as President, Chief Executive Officer & Director from 2006 to 2012, Anacor Pharmaceuticals LLC, as Chairman, President & Chief Executive Officer from 2014 to 2016, and various other companies.
Mr. Berns received his undergraduate degree from the University of Wisconsin.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 20.08.2026 | 7 708 851 ( 4,1 % ) | 10 Mio $ | 31.08.2026 | |
0,02 % | 22.06.2026 | 20 706 ( 0,02 % ) | 417 433 $ | 31.08.2026 |
Aktive Positionen von Paul Berns
| Unternehmen | Position | Beginn |
|---|---|---|
| NEUMORA THERAPEUTICS, INC. | Gründer | 01.11.2019 |
Epirium Bio, Inc.
 Epirium Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for rare diseases characterized by impairment of the skeletal muscle, cardiac and neuronal systems | Direktor/Vorstandsmitglied | - |
Elephas Biosciences Corp.
 Elephas Biosciences Corp. Packaged SoftwareTechnology Services Develops software platform for cancer patients | Direktor/Vorstandsmitglied | 07.09.2022 |
EQRx International, Inc.
 EQRx International, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines | Direktor/Vorstandsmitglied | 01.01.2020 |
Happy Health, Inc.
 Happy Health, Inc. Medical/Nursing ServicesHealth Services Provides health care services | Direktor/Vorstandsmitglied | 01.08.2019 |
Ehemalige bekannte Positionen von Paul Berns
| Unternehmen | Position | Ende |
|---|---|---|
| UNITY BIOTECHNOLOGY, INC. | Direktor/Vorstandsmitglied | 04.04.2025 |
HIBio, Inc.
 HIBio, Inc. BiotechnologyHealth Technology Develops transformative therapies | Gründer | 01.07.2024 |
| EQRX, INC. | Direktor/Vorstandsmitglied | 09.11.2023 |
| JAZZ PHARMACEUTICALS PLC | Direktor/Vorstandsmitglied | 29.07.2021 |
Ausbildung von Paul Berns
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
74
Beziehungen ersten Grades
28
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 28 |
|---|---|
Abbott Laboratories
 Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
Bone Care International, Inc.
 Bone Care International, Inc. Pharmaceuticals: OtherHealth Technology Developed innovative therapeutic and pharmaceutical products | Health Technology |
Allos Therapeutics, Inc.
 Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets anti-cancer therapeutics | Health Technology |
ARCH Venture Partners LLC
 ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners invests in disruptive science companies located in the United States. The firm target companies operating in the fields of biotechnology and technology sectors. It provides financing for early stage capital requirements with a minimum investment size of $0.05 million and also makes co-investments. | Finance |
Jazz Pharmaceuticals, Inc.
 Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Health Technology |
Ren Pharmaceuticals, Inc.
 Ren Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceuticals products | Health Technology |
Epirium Bio, Inc.
Epirium Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for rare diseases characterized by impairment of the skeletal muscle, cardiac and neuronal systems | Health Technology |
Menlo Therapeutics, Inc.
 Menlo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of serlopitant products | Health Technology |
Knoll AG
 Knoll AG Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
XenoPort, Inc.
 XenoPort, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing and commercializing of pharmaceutical products for the potential treatment of neurological disorders | Health Technology |
BASF SA
 BASF SA Chemicals: Major DiversifiedProcess Industries Manufactures chemicals and agricultural products | Process Industries |
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novelos Therapeutics, Inc.
 Novelos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and provides pharmaceutical drugs | Health Technology |
Anacor Pharmaceuticals LLC
 Anacor Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a bio pharmaceutical company | Health Technology |
Jazz Pharmaceuticals Plc
 Jazz Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of pharmaceutical products to treat neurological disorders | Health Technology |
Cellectar Biosciences, Inc.
 Cellectar Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that is engaged in developing compounds for the treatment and imaging of cancer | Health Technology |
BlackThorn Therapeutics, Inc.
 BlackThorn Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets medicines for neuron developmental disorders | Health Technology |
Unity Biotechnology, Inc.
 Unity Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Develops senolytic medicines and biotechnology therapies targeting age-related diseases & ophthalmologic conditions | Health Technology |
Mc2 Therapeutics AS
 Mc2 Therapeutics AS Pharmaceuticals: MajorHealth Technology Manufactures therapies for chronic inflammatory diseases | Health Technology |
EQRx International, Inc.
EQRx International, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines | Health Technology |
VYNE Therapeutics, Inc.
 VYNE Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Happy Health, Inc.
Happy Health, Inc. Medical/Nursing ServicesHealth Services Provides health care services | Health Services |
EQRx, Inc.
 EQRx, Inc. Pharmaceuticals: MajorHealth Technology Develops and delivers medicines for lung cancer | Health Technology |
HIBio, Inc.
HIBio, Inc. BiotechnologyHealth Technology Develops transformative therapies | Health Technology |
Neumora Therapeutics, Inc.
 Neumora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops medicines for brain diseases | Health Technology |
Elephas Biosciences Corp.
Elephas Biosciences Corp. Packaged SoftwareTechnology Services Develops software platform for cancer patients | Technology Services |
Areteia Therapeutics, Inc.
 Areteia Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company | Health Technology |
Human Immunology Biosciences, Inc.
 Human Immunology Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on developing therapies for immune-mediated diseases | Health Technology |
